Urinary angiotensinogen (uAGT) is a novel biomarker of the activation of the renin–angiotensin system (RAAS) in patients with ADPKD, and it is associated with hypertension, progressive kidney damage, proteinuria, and cardiovascular morbidity and mortality. Here, AGT is linked to Hypertension.